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Abstract
The structure/function relationship is fundamental to our understanding of biological systems at all levels, and drives most, if
not all, techniques for detecting, diagnosing, and treating disease. However, at the tissue level of biological complexity we
encounter a gap in the structure/function relationship: having accumulated an extraordinary amount of detailed
information about biological tissues at the cellular and subcellular level, we cannot assemble it in a way that explains the
correspondingly complex biological functions these structures perform. To help close this information gap we define here
several quantitative temperospatial features that link tissue structure to its corresponding biological function. Both
histological images of human tissue samples and fluorescence images of three-dimensional cultures of human cells are used
to compare the accuracy of in vitro culture models with their corresponding human tissues. To the best of our knowledge,
there is no prior work on a quantitative comparison of histology and in vitro samples. Features are calculated from graph
theoretical representations of tissue structures and the data are analyzed in the form of matrices and higher-order tensors
using matrix and tensor factorization methods, with a goal of differentiating between cancerous and healthy states of brain,
breast, and bone tissues. We also show that our techniques can differentiate between the structural organization of native
tissues and their corresponding in vitro engineered cell culture models.
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Introduction
Heart disease and cancer remain the top two causes of death in
the US. One fundamental characteristic of both diseases is tissue
failure: namely, errors in the structural organization and function of
cells in the affected tissues. Traditional approaches for uncovering
the source of these errors have relied heavily on reductionist
approaches (e.g., genomics, proteomics, gene expression micro-
arrays), yielding tremendous amounts of information about the
genetic and biochemical makeup of these cells. Yet, the
fundamental question remains: exactly what cellular structures
and functions initiate the transition from healthy to diseased
tissues, and why? We believe that one reason we have yet to
answer this question is that the structure/function paradigm has
developed a ‘‘gap’’ at this critical cell-to-tissue level; we have
accumulated more information than we can integrate into a cell/
tissue-level understanding of disease, such that the abundance of
genetic and biochemical details are not being fully utilized to
uncover how cells and tissues function. Likewise, we have an
abundance of markers for many diseases, but we don’t fully
understand the rules that link the molecular constituents of
diseased tissues to the clinical symptoms of the disease itself.
A dramatic example of this problem lies in the detection and
diagnosis of cancer, where, despite a multitude of genetic screens,
biochemical assays, and imaging techniques, the ‘‘gold standard’’
for diagnosis remains the expert opinion of highly trained
pathologists who visually scan samples of the tissues in histology
slides. In other words, the human eye is currently the most accurate
tool we have available for identifying telltale alterations in the
structure and function of diseased tissues. The same is true for
diagnosis of heart disease, arthritis, and most other debilitating
diseases. We believe that a more rigorous approach to linking the
structural organization of healthy and diseased tissues to
fundamental cellular behaviors will help close the gap in tissue
structure/function, and provide clinicians a powerful tool for more
accurately detecting and diagnosing disease.
Numerous techniques have been developed to extract informa-
tion at the molecular, cellular, tissue or organ level to distinguish
and classify distinct disease types, such as tumor types in cancer
but none of these approaches can model the structure-function
relationship in tissues as we discuss in the next section. In this
paper, through the use of graph theoretical tissue representation
[1], we model the structure-function relationship in tissues.
Furthermore, our approach combines this representation with
matrix and tensor factorization methods in order to identify sets of
structural properties that discriminate between healthy and
cancerous forms of three morphologically distinct tissues (brain,
breast, and bone) and quantify the structural differences between
these tissues and their tissue engineered counterparts. Both
histological images of human tissue samples and fluorescence
images of three-dimensional cultures of human cells are used to
compare the accuracy of in vitro culture models (3D cell cultures
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32227and in vitro samples will be used interchangeably in the
manuscript) with their corresponding human tissues (referred to
as histology samples throughout the paper). To the best of our
knowledge, there is no prior work on a quantitative comparison of
histology and in vitro samples.
Methods
1. Tissue and Cellular Analysis
In the literature, four different types of approaches have been
used to define quantitative features at the cellular and tissue levels.
The first uses morphology to quantify the size and shape of a cell
or its nucleus [2–7]. The second employs intensity or the
distribution of the color values of pixels to define features [8–
11]. The third exploits textural descriptors and considers spatial
dependency of the intensity values to quantify the smoothness,
regularity or coarseness of the image [2,5,6,12–17]. Finally, the
fourth approach, which most closely resembles ours, is based on
drawing a Voronoi graph of cells from a tissue image and
computing graph-theoretical features that quantify how the cells
are distributed over the tissue [7,8,18]. Nevertheless, none of these
approaches can model the structure-function relationship in
tissues.
2. Cell-graph Mining of Tissue Structures
Recently we introduced a powerful technique called the cell-
graphs to model structural organization of histology tissue samples.
Cell-graphs capture the characteristic structural properties that
distinguish healthy, damaged, and cancerous states of brain
[1,19,20,21], breast [22], and bone tissues [23]; and properly
classify follicular lymphoma [24]. We further extended this
method for in vitro studies to model mesenchymal stem cells in
three dimensional space [25], to ECM interactions during cell-
mediated compaction and collagen remodeling in 3D [26], and to
in vitro cancer data analysis, as explained in [27]. We also showed
preliminary results of the applicability of cell-graph technique for
capturing the distinctive epithelial and mesenchymal features in an
embryonic branching organ – the salivary gland [28].
2.1 Data Acquisition. In this manuscript we used the
histopathology data as explained in our previous publications
[1,19–22] and in vitro cancer data [27]. Below we summarize the
basic techniques and details of the data.
N Histopathology Data Acquisition: Our data has two different
functional states (healthy and cancerous) of three different tissue
types: brain, bone and breast. The data used in the study follows
the specifics below:
Our brain tissue data set is a mixture of healthy tissue and
diseased (glioma) samples. For preliminary studies, these tissues are
randomly selected by a neuropathologist from Oregon Health and
Science University (OHSU) Pathology Department archives,
arbitrarily limiting the search to the years 2001–2004, and
selecting well-preserved, technically adequate samples that best
represent the different tissue states mentioned earlier, without
excluding any particular patient population. Healthy tissue
samples were taken when available from surgical specimens or
autopsies. All diseased (glioma) samples were high-grade; and
glioblastoma, anaplastic astrocytoma and anaplastic oligodendo-
glioma were included as diagnostic categories. Each sample
consists of a 5–6 mm thick tissue section stained with hematoxylin
and eosin (H&E) technique and mounted on a glass slide. In each
case, a representative H&E-stained glass slide was chosen by the
pathologist, and the patient identifiers (i.e. the accession numbers
on slide labels) were removed after diagnostic tabulation in a
coded manner. Subsequently, digital photomicrographs of differ-
ent fields of the lesion were obtained in a standardized way in a
Nikon Coolscope digital camera/scanner by the pathologist.
Uniformity of the images was obtained by keeping the magnifi-
cation and illumination at selected levels, allowing sufficient
resolution to detect individual tumor cell nuclei. Special attention
was given to avoid areas of hemorrhage and necrosis, treatment
effects, blood vessels and tissue artifacts. Different sets of pictures
were obtained of the tumor parenchyma, interface of the tumor
and the surrounding brain, and histologically normal areas when
available. Areas of low and high cellularity were also sampled as
images in different entities. Prior to segmentation, we converted
the RGB values of pixels to their corresponding values in the
La*b* color space. Unlike the RGB color space, the La*b* color
space is a uniform color space and the color and detail information
are completely separate entities. Therefore, using the La*b* color
space yielded much better quantization results. Data set in this
study contains 210 images of 14 patients with healthy histology
samples and 329 images of 41 patients with malignant glioma
histology samples.
The data set for breast tissue modeling was randomly
selected from the archived Mount Sinai School of Medicine
(MSSM) Pathology Department archives. The two different states
of breast tissue cases were reviewed by two breast pathologists at
MSSN to reach a consensus. The data set, we used in this study
contains 128 invasive cancerous tissue images of 19 patients, and
195 healthy tissue images from 19 patients.
The data for bone tissue modeling and classification was
provided by the Pathology Department at Hospital for Special
Surgery (HSS) in NYC. H&E stained images of two different states
of bone tissue (healthy and diseased [cancerous]) were collected
with 106magnification. The data set used in this study contains
20 images of healthy bone tissue, and 49 images of osteosarcoma
(diseased) bone tissue.
N In Vitro Data Acquisition: Regarding to the cell culture
techniques, the different cell types and their respective culture
conditions are listed in Table 1 and the functional categories of
each cell type are listed in Table 2 of our previous work in [27].
For fluorescence imaging, gels were fixed using 3% paraformal-
dehyde at 11 different time points (hours): 0, 1, 2, 4, 6, 10, 16, 24,
72, 120, 168. Each was washed with PBS, then stained with
nucleic acid dye (sytox green). Images of cells encapsulated within
collagen-I hydrogels were captured using a Zeiss LSM 510 META
confocal microscope with a 106dry objective. Representative Z-
stack images of 100 mm thickness with 900 mm6900 mm cross-
section area were collected for five samples of each time point.
2.2 Cell Graph Construction and Feature
Extraction. Our overall methodology used for obtaining the
cell-graphs in this work can be summarized in two phases. First,
we build 2D cell-graphs to represent a tissue state (Figure 1
illustrates the cell graphs for different tissue types and states).
Second, the graph theoretical features of these cell-graphs are
computed.
In cell-graph generation phase, we have three steps: (i) color
quantization, (ii) node identification, and (iii) edge establishment.
Details of these steps can be found in our cited publications above.
We explain these steps briefly here:
N Image Processing and Segmentation: In this step we used
standard image processing tools to distinguish the cells from their
background based on the color information of the pixels. For that
we use the k-means algorithm. The k-means algorithm clusters the
data based on their features. There are k cluster vectors and each
sample is assigned to its closest cluster and represented with this
clustering vector. Subsequently, each of these clustering vectors is
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pathologists.
N Node Identification Step: In a cell-graph, cells or cell clusters
of a sample tissue are the vertices. We have several methods to
extract vertices of a cell graph from data. The method applied to
the histology data used in this manuscript can be described as
follows: In the node identification step, we translate the class
information of the pixels to the node information of a cell-graph.
In this step, we have two control parameters: (i) the size of the grid,
and (ii) the threshold value. The grid size determines the down
sampling rate, i.e., the resolution of the resultant image. After this
step, a node can represent a single cell, a part of a cell, or a bunch
of cells, depending on the grid size. We embed a grid over the
tissue image and assign a value of 1 to the pixels of ‘‘cell’’ class and
a value of 0 to the pixels of ‘‘background’’ class. Subsequently, for
each grid entry, we compute a probability of being a cell or
background by computing the average values of pixels located in
this grid entry. At the end of this step, the spatial information of
the cells is translated to their locations in the two-dimensional grid.
After computing the probabilities, we compare these against a
threshold value. The grid entries with a probability value greater
than the threshold are considered as the nodes of the cell-graph.
Thus, the second control parameter is the threshold value, which
eliminates the noise that arises from the stain artifacts and mis-
assignment of black pixels in the color quantization step.
Considering the large number of images that need to be
processed, we employ Otsu’s simple but effective automatic
threshold selection algorithm that determines a global (single)
threshold for the image based on the histogram of image values.
Each connected component in the resulting binary image
corresponds to a nucleus and the coordinates of the centroids of
these nuclei are calculated to identify the coordinates of the node
(vertex) set for cell-graph generation.
N Edge Establishment Step: In the edge establishment step, we
set the links between the nodes to generate a cell-graph. Formally,
let G~(V,E) denote a cell-graph with V and E being the set of
nodes and edges of the graph, respectively. After determining V in
the node identification step, we define an edge (u, v) between a
pair of nodes u and v by making use of the biological insight and
knowledge on the interaction of the cells in a specific tissue type.
For example, it may be more likely that physically adjacent cells
signal each other than the ones far away. Such distance based
interaction among the elements is well understood in physical
systems based on energy minimization. In the absence of multiple
markers (recall that images are H&E stained) we rely on a
proximity based establishment of pairwise relationships between
nodes. Therefore, we translate the pairwise spatial relation
between every two nodes to the possible existence of links in a
cell-graph. We can establish the edges probabilistically or
deterministically or use a combination of these two methods. For
example, in [1] we constructed probabilistic cell-graphs in which
the probability of creating a link between any two nodes decays
exponentially with the Euclidean distance between them with a
function P(u,v)~ae{d(u,v)=BL, or with a power law probability
function such that P(u,v)~d(u,v)
{a where d(u, v) is the distance
between these nodes. Intuitively, the closer two cells are, the more
likely that they share a relationship. This probability quantifies the
possibility for one of these nodes to be grown from the other thus,
aiming to model the prevalence of the disease state in a tissue.
An edge (u, v) can also be deterministically established if the
distance d(u, v) is less than a threshold (e.g., two cells are physically
touching each other). This is indeed the method used for
constructing the cell-graphs analyzed in this paper. The
motivation is that if cell membranes are touching or close enough
(we quantify this by parametric search) then there is some signaling
between them. We have identified link thresholds, corresponding
to the approximate radii of spread mammalian cells, of 65, 70, and
75 microns (from a distortion free sphere representation of the cell
membrane to observable distortion) and performed parametric
search to maximize the classification accuracy of our modeling.
Note that the presence of a link between nodes does not specify
what kind of relationship exists between the nodes (cells); it simply
indicates that a relationship of some sort is proposed to exist, and
that it is dependent on the distance between cells. Surprisingly, the
distance measure alone is sufficient to reveal important, diagnostic
structural differences in human tissues.
If the images carry multichannel information by applying more
sophisticated staining techniques (e.g., multispectral fluorescence
imaging), it is possible to build cell-graphs that have different types
of nodes corresponding to different types of cells that co-exist (e.g.,
epithelial vs. fibroblast) and other ECM entities (e.g., basement
membrane underlying epithelial cell layers and blood vessels).
With 3D images and 3D cell-graphs, such representation becomes
more accurate and powerful; this is indeed currently investigated
by our group.
The second phase is feature extraction from cell graphs. The cell-
graphs enable us to apply well-established principles of graph
theory and provide a rich set of features defined precisely by these
principles to be used as quantitative descriptor features. They can
Figure 1. Examples of different tissue types and states as well
as their representations as cell-graphs.
doi:10.1371/journal.pone.0032227.g001
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clustering coefficient, giant connected component; distance indica-
tors such as diameter, radius, hop plot exponent; compactness
indicators such as closeness, central points, isolated points, link
lengths. We showed in our previous work that these features obtain
different values based on different functional states thus one can
train classifiers to quantify the relationship between feature values
and functional states [1,19–27]. The features we included in this
paper are the ones used commonly in our previous work and listed
in Table S1.
We consider two types of features: (i) local features at the
individual cell level, and (ii) global features at the tissue level to be
used by the algorithms to distinguish different tissue types. By
computing the distribution of local features, we can obtain global
features. However, some global features can only be computed
over the entire graph. For example the ratio of the size of the giant
connected component over the size of the entire graph can be used
as a global feature. Other global features are related to the
spectrum of a graph, which is the set of graph eigenvalues
computed from the adjacency matrix or its Laplacian. The
spectral radius and eigen exponent are such features. The
eigenvalues of the Laplacian relate to the graph invariants better
than the eigenvalues of the adjacency matrix. For example, the
number of eigenvalues with a value of 0 gives the number of
connected components in the graph. Moreover, as the eigenvalues
of the Laplacian lie in the range of [0,2], it is easier to compare the
spectra of graphs with different sizes. We also use global features to
characterize the spectra of cell-graphs, i.e., the eigenvalue
distribution of the Laplacian of the cell-graph. While some of
these features are easier to relate to underlying biology such as
degree, closeness; some others are hard to associate with biology
such as the spectral one. However, these features collectively
describe the structural organization of underlying tissue sample as
we demonstrated in our previous work.
3. Matrix and Tensor Factorizations
Using cell-graph features, the data can be arranged as a matrix
(cell-graph features by histology samples) or a three-way tensor
(cell-graph features by in vitro samples by time) (see Figure 2). We
analyze the data arranged as in Figure 2 to (i) differentiate between
different tissue functional states, (ii) identify the features respon-
sible for such differentiation, and (iii) discriminate between
histology samples and their corresponding in vitro engineered cell
cultures using matrix and tensor factorizations.
Matrix factorizations, in particular Singular Value Decompo-
sition (SVD) [29], are commonly used for exploratory data analysis
to extract the underlying factors in complex data sets [30]. Given a
matrix X[R
I|J of rank R, SVD computes orthogonal matrices
U[R
I|I and V[R
J|J such that X~USVT, where S is a diagonal
matrix with s1, s2, …sR on the diagonal and s1$s2$…$sR. The
columns of U and V are the left and right singular vectors, respectively,
and the diagonal entries of S are the singular values. In order to find
a low-rank approximation of the data, we can use only the first K
(K,R) singular values and vectors; and this gives the best rank-K
approximation of the data (Figure 3a).
Tensor factorizations are generalizations of matrix factoriza-
tions to higher-order tensors. An N-way tensor (or an Nth-order
tensor) is a multidimensional array represented using N indices,
e.g., a vector is a first-order tensor; a matrix is a second-order
tensor. N-way arrays, for N§3, are called higher-order tensors.
Here, we use one of the most popular tensor models, i.e.,
CANDECOMP/PARAFAC (CP) [31,32], which has proved
useful for finding the underlying structures of higher-order data
sets in various disciplines such as chemometrics, computational
neuroscience and social network analysis [33,34]. Given a tensor
X[R
I|J|K, its R-component CP factorization is expressed as
follows:
X&
X R
r~1
ar0 br0 cr,
where 0 denotes the vector outer product, and ar[R
I, br[R
J, and
cr[R
K for r=1,…,R. The matrices A~½a1 a2 :::aR [R
I|R,
B~½b1 b2 ::: bR [R
J|R and C~½c1 c2 ::: cR [R
K|R correspond
to the CP factor matrices (component matrices) extracted from the first,
second and third mode (or dimension) of the tensor, respectively. We
use the compact notation, X& DA,B,CD ½  to denote the CP model
[34]. Just as SVD represents a matrix as a sum of rank-one
Figure 2. Analysis of histology and in vitro data sets using
coupled matrix and tensor factorization (CMTF). Time mode is
slotted as 0, 1, 2, 4, 6, 10, 16, 24, 72, 120, 168 in hours. Features mode
contains the cell graph features: average degree, clustering coefficient
C, clustering coefficient D, clustering coefficient E, average eccentricity,
diameter, radius, average eccentricity 90, diameter 90, radius 90,
average path length, effective hop diameter, hop plot exponent, giant
connected component ratio, # connected components, average
connected component size, % isolated points, % end points, # central
points, % central points, mean, std, skewness, kurtosis, # nodes, #
edges. These features are defined in Table S1.
doi:10.1371/journal.pone.0032227.g002
Figure 3. Singular Value Decomposition and R-component CP
model.
doi:10.1371/journal.pone.0032227.g003
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tensors (Figure 3b).
4. Joint Analysis of In vitro and Histology Samples
While clinical biopsies (histology samples) represent the current
standard for determining human tissue state, their limited
availability, sample variability, and high cost are often prohibitive
for studying the underlying mechanisms that control tissue
function. Despite their limited simplicity, three-dimensional
engineered cultures of human cells grown in vitro offer the
advantages of providing complete control over environmental
conditions and permitting invasive analyses that are difficult or
impossible to perform with human subjects. The costs and benefits
of using histology and in vitro samples are therefore an important
consideration in any study of tissue structure and function. In this
study, we used image data from both sources.
Joint analysis of data from multiple sources can improve our
understanding of the underlying structures in complex data sets.
For instance, we represent our in vitro samples as a set of features
changing over time, which forms a third-order tensor with modes:
Figure 4. Three-way and Two-way analysis of in vitro brain tissue data. (a) CP factorization of the tensor with modes: features, samples and
time. The 1st component separates the 2 different functional states: cancer (red-triangle sign) from normal (green-plus sign) tissue samples; (b) SVD of
matrix of type: features by samples (across all times); (c) features projected over the 1st component of the CP model. Cell-graph features such as %o f
end points, number of connected components, average connected component size, average path length, average eccentricity are identified as influential
in the analysis since their coefficients diverge the most from zero. (Note that we have 23 features on the plot since three features have been identified
as outliers and excluded).
doi:10.1371/journal.pone.0032227.g004
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the same set of features as a features by samples matrix. By analyzing
these two datasets (arranged as in Figure 2) jointly and extracting
the same factors from the features mode, we may capture the
common dynamics in both in vitro and histology samples. We can
then use these dynamics to differentiate between different tissue
functional states or to understand what features are influential for
differentiating between those functional states.
We analyze the two data sets in Figure 2 using coupled matrix
and tensor factorizations [35]. Given a third-order tensor
X[R
I|J|K and a matrix Y[R
I|M
, the tensor and the matrix
are factorized jointly using coupled matrix and tensor factorization
(CMTF), where an R-component CMTF model of a tensor X and
a matrix Y can be computed by solving the following optimization
problem:
min
A,B,C,D
DDX{ DA,B,CD ½  DD
2zDDY{ADTDD
2
where A is the factor matrix corresponding to the common mode,
i.e., features modes; B, C,and D correspond to factor matrices in
other modes. DD:DD denotes the norm of a tensor and it is defined as
DDXDD
2~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P I
i~1
P J
j~1
P K
k~1
x2
ijk
s
. We solve the optimization problem by
Figure 5. Coupled matrix and tensor factorization (CMTF) on in vitro brain samples represented by tensor X and histology samples
represented by matrix Y (see Figure 2). (a) The first column of matrix B, that is the factor matrix corresponding to the in vitro samples mode
extracted using CMTF, separates cancer (blue-square signs) from normal (light blue-plus signs) tissue samples; (b) The first column of matrix D, that is
the factor matrix corresponding to the histology samples mode extracted using CMTF, can separate cancer (red-triangle sign) from healthy (green-
star sign) samples; (c) features captured by the common component extracted by CMTF.
doi:10.1371/journal.pone.0032227.g005
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e32227Figure 6. Three-way and two-way analysis of in vitro bone tissue data. (a) CP factorization of the tensor with modes: features, samples and
time. Both the 1st and the 2nd components separate the two different functional states: cancer (red-triangle sign) from normal (green-plus sign)
tissue samples; (b) SVD of matrix of type: features by samples (across all times); (c) features projected over the 1st component of CP model. Cell-graph
features such as % of end points, number of connected components, giant connected component ratio, average path length, average eccentricity are
identified as influential in the analysis since their coefficients diverge the most from zero; (d) since the 2nd component can also distinguish between
two functional states we also show the 2nd CP component in features mode. Note that the influential features are different in the 2nd component,
e.g., while the number of connected components has a high coefficient in the 1st component, its coefficient in the 2nd component is close to 0.
doi:10.1371/journal.pone.0032227.g006
Figure 7. Coupled factorization of in vitro bone samples represented by tensor X and histology samples represented by matrix Y.
(a) Both the 1st and the 2nd column of matrix B extracted by a CMTF model separate cancer (blue-square sign) from normal (light blue-plus sign)
samples; (b) Matrix D corresponding to the histology samples mode extracted using a CMTF model is useful to narrow the coupled analysis since only
the 1st component can separate cancer (red-triangle sign) from healthy (green-star sign) samples; (c) features captured by the 1st CMTF component.
doi:10.1371/journal.pone.0032227.g007
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gradient is computed by taking the partial derivative of the
objective function with respect to each factor matrix and
concatenating the derivatives and then we use Nonlinear
Conjugate Gradient to solve the CMTF problem [35].
Results
1. Normal vs. Cancer: Brain Tissues
Our first objective was to test whether the same cell-graph
feature set we used to classify biopsy (histology) samples of brain
[1], breast [22], and bone [23] tissues would be sufficient to permit
us to properly segregate 3D engineered cell cultures containing
healthy or cancerous cells from the same tissues [27]. These
cultures are simpler than their native counterparts, because they
contain only one cell type, and thus cannot recapitulate the full
structure or function of their tissue of origin. However, because
they begin as diffuse clusters of cells encapsulated in a collagen gel,
they are far more disorganized than even the most cancerous
tissues, and thus undergo a complex series of morphological
changes (e.g., gel compaction, establishment of cell-cell junctions,
etc.) that do not normally occur in histology samples. In fact, most
modern 3D cell cultures undergo transformations that more
closely resemble wound healing than embryonic development.
Figure 8. Three-way and two-way analysis of in vitro breast tissue data. (a) CP factorization of the tensor with modes: features, samples and
time. Only the 2nd component can separate the two different functional states: cancer (red-triangle sign) from normal (green-plus sign) tissue
samples; (b) SVD of matrix of type: features by samples (across all times); (c) features projected over the 2nd CP component. Cell-graph features such
as % of end points, number of connected components, average connected component size, average path length, average eccentricity are identified as
influential in the analysis.
doi:10.1371/journal.pone.0032227.g008
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measured at different time points as a features by samples by time
tensor. Let X denote this tensor. We compute its CP factorization,
i.e., X& DA,B,CD ½  , and extract the factor matrices A, B and C
corresponding to the features, samples and time modes, respec-
tively. In our analysis, a 2-component CP model is used and the
number of components is chosen based on the core consistency
diagnostic [36]. We focus on the component matrices in features
and samples mode. Figure 4a shows the scatter plots of the factors
in the samples mode, i.e., b1 vs: b2. Figure 4c illustrates the first
factor in the features mode, i.e., a1, since the first component
differentiates between cancerous and healthy samples in Figure 4a.
We also matricize tensor X, in the first mode by arranging the
tensor as a features by samples-time matrix (see [33] for matriciza-
tion), and compute its SVD. Figure 4b shows the scatter plot of the
right singular vectors, i.e.,v1 vs: v2.
The results in Figure 4 illustrate three important aspects of our
analysis. First, healthy and cancerous brain cells grown in 3D
culture (in vitro samples) can be discriminated when we represent
them using cell-graph features and take into account how they
change in time. Three-way analysis can easily discriminate
between them (Figure 4a) (We also illustrate that it is not possible
to separate brain cells at every time sample as healthy or cancerous
(Figure 4b)). Second, this discriminative power relies primarily on
a small subset of the graph features, suggesting they may contain
the telltale signatures of functional state, even in 3D monoculture.
Figure 9. Coupled matrix and tensor factorization on in vitro breast samples represented by tensor X and histology samples
represented by matrix Y (Figure 2). (a) The 1st column of matrix B corresponding to the in vitro samples mode extracted by a CMTF model can
separate cancer (blue-square sign) from normal (light blue-plus sign) tissue samples; (b) Unlike for brain and bone tissues, matrix D corresponding to
the histology samples mode extracted using a CMTF model cannot separate cancer samples (red-triangle sign) from healthy (green-star sign)
samples; (c) features captured by the common component extracted by CMTF. Cell-graph features identified as influential in the coupled analysis are
similar to the features in Figure 5c and 7c with some minor differences.
doi:10.1371/journal.pone.0032227.g009
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and molecular changes that occur during malignant transforma-
tion. For example, the features # connected components, % end points,
and average connected component size reflect the degree of ‘‘commu-
nication’’ between nodes in a cell graph; as healthy brain becomes
cancerous in vivo, much of this communication is lost due to loss of
synaptic junctions, although the relative position of the cell bodies
may not change much. As the tumor cells proliferate, the increased
number of cells becomes an obvious distinguishing feature,
reflected in our analysis by the metric # nodes. By comparison,
the mean indicating the average edge length is of relatively low
diagnostic value, and contributes very little to the first component
of our three way analysis. Third, because these features are also
quantitative, we now have a statistically rigorous means of
classifying functional state based on the same raw data that
generate qualitative classifications in the clinic.
We gain additional insight by adding the histology samples to
our analysis. We represent them as a matrix of type: features by
samples, using the cell-graph features. This yields two sources of
information: (i) in vitro samples arranged as a tensor (see tensor X
in Figure 2) and (ii) histology samples arranged as a matrix (see
matrix Y in Figure 2). These data sets are coupled in the features
mode in that they use the same set of cell-graph features. Using
coupled matrix and tensor factorizations, we factorize tensor X
and matrix Y in such a way that X& DA,B,CD ½  and Y&ADT,
where A corresponds to the common factor matrix in the features
mode. B and C represent the factor matrices for samples (in vitro)
and time modes, respectively while D is the factor matrix
corresponding to the histology samples. In coupled analysis, we
observe that there is only one common component (Extracting
more components results in degenerate models, where one
component is highly negatively correlated with another compo-
nent - see [34] for a discussion on degeneracy in the case of tensor
factorizations). Figure 5a plots the factor vector in the in vitro
samples mode, i.e., b1, while Figure 5b plots the factor vector in
the histology samples mode, i.e., d1. The common factor can
differentiate between cancer and healthy samples in both Figure 5a
and Figure 5b. In Figure 5c, we illustrate the common factor in the
features mode, i.e., a1, in order to see the features responsible for
the differentiation of functional states.
The results in Figure 5c further demonstrate that subsets of
graph features can successfully separate distinct functional states in
structurally similar tissues. Note that three-way analysis and
coupled analysis produce similar feature sets to distinguish healthy
and cancerous forms of human tissue samples. This is expected
since our analysis targets only the spatial distribution of nuclei
(although tissue biopsies contain far more structural complexity
than 3D in vitro monocultures of healthy and cancerous cells,).
Figure 10. In vitro vs. histology samples of cancerous tissue (10a Brain, 10b Bone, and 10c Breast samples). The first two components
of SVD analysis explain 72.4%, 65.9%, 66.5% of the variance for each tissue type, respectively. SVD yields a linear separation between in vitro and
histology cancerous tissue samples. Two clusters (red and green) are very well separated, with few outliers. This defines and quantifies a structural
difference between engineered tissues and the native tissues.
doi:10.1371/journal.pone.0032227.g010
Figure 11. In vitro vs. histology samples of normal tissue (11a Brain, 11b Bone, and 11c Breast samples). The first two components of
SVD analysis explain 76.5%, 75%, 62.8% of the variance for each tissue type respectively and shows that there is a linear separation of in vitro and
native healthy tissue samples. The separation confirms that recreating the complex structural organization of native tissue samples in vitro is difficult.
doi:10.1371/journal.pone.0032227.g011
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connected component ratio are global features that capture patterns
across the entire graph.
2. Normal vs. Cancer: Bone Tissues
We repeated the analysis for bone samples (obtained in our
previous study [23]) by constructing a third-order tensor with
modes: features, samples, and time, and computing its CP
factorization. Similar to Figure 4a, in Figure 6a, we show the
scatter plots of the factors in the samples mode. We observe that
both the first and second factors can separate the healthy and
cancerous in vitro samples. Figure 6c and 6d, therefore, illustrate
the first and second factors in the features mode. As in Figure 4b,
Figure 6b shows the scatter plot of right singular vectors of tensor
X matricized in features mode. The results in Figure 6 are similar
to those in Figure 4, in that three-way analysis can separate the
healthy and cancerous in vitro samples. This is significant because
it demonstrates that the discriminative power of our analysis is
independent of cell/tissue type. While brain and bone tissues are
morphologically quite distinct, our analysis reveals they share
many of the same core structural features. When we compare the
significant features in Figure 6c to those in Figure 4c, we see a
great deal of overlap, suggesting that the first component of our
CP analysis of bone cultures exhibits a discriminative power
similar to the first CP component for our in vitro brain samples. In
addition, the second component of our in vitro bone analysis
(Figure 6d) contains additional significant features.
In Figure 7, we illustrate the results of coupled analysis of in
vitro and histology samples. In this case, it is possible to extract two
common factors. Figure 7a plots the factors in the in vitro samples
mode, i.e., b1vs: b2, while Figure 7b plots the factor vector in the
histology samples mode, i.e., d1vs: d2. The first common factor
can differentiate between cancer and healthy samples in both
Figure 7a and Figure 7b; therefore, we illustrate a1 in Figure 7c to
show the features responsible for the differentiation in both
histology and in vitro samples. A comparison of Figure 5 and
Figure 7 illustrates that our coupled matrix-tensor analysis is
equally powerful for classifying in vitro brain and bone samples,
and that this classification relies on a similar set of features for both
tissue types. This strongly suggests that our analysis of combina-
tions of cell-graph features from histology and in vitro samples,
even from morphologically distinct tissues, converges on a core set
of features that serve as tissue signatures, defined in large part by the
global organization of the entire tissue. Note that while the
absolute values of these features may differ considerably between
different tissue types, we feel the fact that these signatures are
composed of a small set of features uncovers a key underlying
organizational principle in tissue structure and function, and thus
may be important for closing the gap in our understanding of
tissue structure and function.
3. Normal vs. Cancer: Breast Tissues
Figure 8 extends our conclusions from Figures 4 and 6 to include a
ductal tissue as well. Of the three tissue types we examined,breast tissue
structure is by far the easiest to understand intuitively: it is primarily
organized into ducts lined with secretory cells, and clear boundaries
(the basement membranes) separate these secretory cells from the
remainder of the cells in this tissue. Our 3D monocultures of normal
breast cells recreate this epithelial architecture quite well, including the
basement membranes. In contrast, our breast cancer cell cultures are
far more diffuse, reflecting the loss of structural integrity in breast
tumors. It is perhaps somewhat surprising, therefore, to see that our
three-way analysis is necessary to discriminate between the two sets of
in vitro samples, and that only the second component of this analysis
could achieve true separation. This is important, because it indicates
that our graph features are not simple abstractions of patterns
immediately visible to trained pathologists. Instead, we feel these
features reflect an underlying organizational theme that all tissues
follow, regardless of their visible appearance.
Figure 9 further underscores this point, in that we cannot
discriminate between healthy and cancerous histology samples
(Figure 9b), even when they are coupled to their corresponding in
vitro samples; if the cell-graph features reflected obvious visible
patterns, we would expect to segregate them. On the other hand,
we find that the common component extracted by our coupled
analysis (only one component is extracted using CMTF) is
sufficient to differentiate between healthy and cancerous in vitro
samples (Figure 9a). The most influential features in the common
component are nearly identical to those that discriminate brain
and bone samples. Collectively, these findings suggest to us that
this small set of features may constitute a global signature for most,
if not all, human tissues.
4. Clustering of In Vitro vs. Histology Samples
Our second objective was to examine the organizational
limitations of our 3D cell cultures vis-a `- vis the actual tissues they
represent. Let Xc and Yc represent the cancerous samples in
tensor X and matrix Y (see Figure 2). We matricize the tensor Xc
Figure 12. In vitro tissue samples remain structurally different from histology samples (blue) over time. We identified no time point in
the development of the in vitro samples that is mathematically similar to histology data. (a) Brain cancer cultures vary considerably over time getting
very close to the histology samples, demonstrating they best resemble the histology samples. In vitro bone cancer (b) and breast cancer (c) samples
remain clustered over all time points and exhibit no mixing of data points with histology data.
doi:10.1371/journal.pone.0032227.g012
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concatenate with Yc forming a new matrix Zc containing both
cancerous in vitro and cancerous histology samples. The SVD of Zc
is computed to see whether we can extract factors that can
differentiate between in vitro and histology samples. The first two
right singular vectors of Zc are plotted in Figure 10 for different
tissue types. Figure 10 illustrates that all three of our in vitro cancer
models are sufficiently different from actual tumors to permit SVD
to clearly segregate them: the first two components of the SVD
analysis capture 72.4%, 65.9%, and 66.5% of the explained
variance for brain, bone and breast tissue samples respectively. The
same is true for our healthy cell cultures (Figure 11): the first two
components of SVD analysis explain 76.5%, 75%, 62.8% of the
variance for each tissue type, respectively. Thus we conclude that in
vitro sample and native histology samples contain quantifiably
different structural organization of cells.
We examined the amount of cumulative explained variance by
3rd, 4th,.. 20th components to see if there is a significant difference
between healthy and cancerous samples when we grow them in vitro
vs. histology. We noticed that explained variance becomes almost
equal for healthy brain and cancerous brain samples by using the first
5 components and thereafter. Similarly for breast tissue samples using
the first 6 components and thereafter equal the explained cumulative
variance for cancerous and health samples. In case of bone tissue the
difference between in vitro and histology is more significant since
c a n c e r o u st i s s u es a m p l ea n a l y s i sr e q u i r e sa l w a y sm o r ec o m p o n e n t s
than healthy one for the same explained cumulative variance. This
observation may indicate that organizing cells in vitro to obtain bone
like tissue samples is a more challenging task.
5. Distance Between Time Evolving In Vitro Data and
Histology Data
Based on our conclusions thus far, our next objective was to
explore whether the accuracy distance between our 3D cultures
and histology samples was time dependent. We hypothesized that
because our 3D cultures undergo much more profound organi-
zational changes than histology samples, their ‘‘accuracy’’
improves as they convert from an initial, evenly dispersed culture
to a more mature structure, then become progressively less
accurate as the cells undergo multiple rounds of mitosis and
apoptosis (a product of the growth factors in the culture media and
decreasing diffusion distance as the gels compact, respectively).
This suggests that each culture reaches a ‘‘peak accuracy’’ over the
course of a seven day incubation.
To test this hypothesis, we compute the SVD of the cancerous
histology samples and project the in vitro samples (at different time
points) onto the first two singular vectors of the histology samples
(after centering/scaling according to histology samples). Figure 12
shows that development of all three in vitro tissue types remains
significantly different from histology samples, and quantifies this
difference between in vitro and native tissue organization. In
addition, while our bone and breast cultures (panels b and c) do
not move closer to their histology sample clusters over time, the
distance of brain cultures varies considerably with time getting
very close to the histology samples, demonstrating they best
resemble the histology samples. These data support our hypothesis
for our brain cultures but fail for bone and breast.
Discussion
There is a huge amount of data collected about biological tissues
at the cellular and subcellular level. However, we still do not have
an understanding of what these structural data corresponds to in
terms of biological functions. In order to address this issue and
improve our understanding of structure/function relationship, in
this paper, we use a set of cell-graph features (see [37] for a review
article) that are capable of modeling the structure/function
relationship in tissues and construct matrices and third-order
tensors representing histology and in vitro samples, respectively.
Using tensor analysis of in vitro samples, for three different tissue
types, i.e., brain, bone and breast, we have demonstrated that it is
possible to discriminate between healthy and cancerous brain cells
grown in 3D culture using a small set of graph features. Besides,
we have shown that we can gain additional insight by
incorporating histology samples and modeling matrices and
third-order tensors jointly through coupled matrix and tensor
factorizations. Joint analysis of histology and in vitro samples
enables us to pinpoint the discriminative features for healthy and
cancerous state separation, e.g., for bone samples in our
experiments. Collectively, our study aims to quantify three
significant but traditionally qualitative structure-function relation-
ships in multicellular organisms:
1. The relationship between relative cell positioning in a
tissue and the functional state of that tissue
Epithelial tissues lose structural integrity when they are
damaged, but recover it as healing progresses; epithelial tumors
also pass through this ‘‘damaged’’ stage, and ultimately lose this
integrity altogether. Discriminating between these not-quite-
healthy conditions is one of the most problematic issues in
pathology. A similar case occurs in bone tissues: a healing fracture
(i.e., fracture callus) so closely resembles osteosarcoma in H&E
sections that physicians amputate the limbs of children as a
precautionary measure. Finally, the treatments for traumatic brain
injury and brain tumors differ significantly, so early and accurate
diagnosis would improve outcomes tremendously. Our approach
places several numeric features on the healthy and cancerous
states, thereby clarifying the most significant differences between
them. Both local and global metrics in our cell graphs define these
features.
2. The relative importance of cell clusters vs. single cells
in the functional state of a tissue
Epithelial cells are literally bound together by a series of cell-cell
junctions that permit them to exchange metabolites, restrict
paracellular transport, and even distribute tensile and compressive
forces across a group of cells, thereby reducing the damage in any
single cell. Osteoblastsmaintainclosecommunication via canaliculi,
and the importance of intercellular contact between neighboring
neurons is unquestioned. Yet, all of these contacts are somewhat
plastic in even healthy tissues. What types of changes in these
connections are permitted in healthy tissues, and when are the
changes so dramatic as to reflect a loss of functional communica-
tion? While the concepts of dynamics of cell-to-cell communication
arewidely accepted,we haveyettodevelop accurateways offinding
the most important signs of meaningful changes in this communi-
cation.Ourlocalmetrics (e.g.,clustering coefficient, degree, etc.)are
representations of this communication between individual cells, and
our global metrics (e.g., number of connected components,
percentage of end points, etc.) sample interactions between
neighboring clusters of cells. The numeric values of these features
collectively quantify the concept of cell-cell cooperativity.
3. The linkage between gene/protein expression and
phenotype in cells and tissues
Reductionist methods have identified thousands of genes in the
human genome, and microarray and proteomic methods can
Coupled Analysis: Structure-Function Relationship
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Yet, a fundamental question remains: what is the relationship
between combinations of genes/proteins and a given phenotype in
a tissue, or even a single cell? This question will remain
unanswered until we develop quantitatively rigorous methods for
defining phenotypic state, comparable to the molecular expression
methods we now use. While we have yet to address this question
directly, the work described in this manuscript provides a
framework for tackling this question in the near future. By
inducing a known change in gene expression in a cell or tissue and
calculating the change in metrics that capture functional state, we
will be better equipped to identify these relationships, which form
the basis of all structure/function studies in multicellular
organisms.
Even though joint analysis of in vitro and histology samples can
improve our understanding, in this paper, we have also studied
organizational limitations of our 3D cell cultures by comparing
them with the actual tissues and demonstrated that there is a
quantifiable structural difference between our in vitro and in vivo
(histology) samples.
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